Benchmarking Outcomes for Molecularly Characterized Synchronous Oligometastatic Non–Small-Cell Lung Cancer Reveals EGFR Mutations to Be Associated With Longer Overall Survival

Local consolidative therapy (LCT) for patients with synchronous oligometastatic non–small-cell lung cancer is an evolving treatment strategy, but outcomes following LCT stratified by genetic mutations have not been reported. We sought to identify genomic associations with overall survival (OS) and p...

Descripción completa

Detalles Bibliográficos
Autores principales: De, Brian, Farooqi, Ahsan S., Mitchell, Kyle G., Ludmir, Ethan B., Lewis, Jeff, Rinsurongkawong, Waree, Rinsurongkawong, Vadeerat, Lee, J. Jack, Swisher, Stephen G., Gibbons, Don L., Zhang, Jianjun, Le, Xiuning, Elamin, Yasir Y., Gomez, Daniel R., Ning, Matthew S., Lin, Steven H., Liao, Zhongxing, Chang, Joe Y., Vaporciyan, Ara A., Heymach, John V., Antonoff, Mara B., Gandhi, Saumil J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2023
Materias:
ORIGINAL REPORTS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9928880/
https://www.ncbi.nlm.nih.gov/pubmed/36716413
http://dx.doi.org/10.1200/PO.22.00540

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9928880/
https://www.ncbi.nlm.nih.gov/pubmed/36716413
http://dx.doi.org/10.1200/PO.22.00540

Ejemplares similares